These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11794101)

  • 1. [Detection and treatment of lower extremity neuropathy in patients with diabetic foot].
    Kucherenko NV; Skrypova TV; Liutkevych VF; Turans'kyĭ AI; Skybun VM
    Klin Khir; 2001 Aug; (8):22-4. PubMed ID: 11794101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of lumbar sympathectomy for the lower extremities diabetic angiopathy in presence of purulent necrotic changes on the foot].
    Shor NA; Chumak IuF
    Klin Khir; 2001 Aug; (8):59-61. PubMed ID: 11794119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of the main arteries in the lower extremities of patients with diabetic foot syndrome].
    Hupalo IuM; Pavliuchyk AV; Makarenko HI; Slobodianiuk IM
    Klin Khir; 2001 Aug; (8):8-10. PubMed ID: 11794131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of vascular therapy in complex of treatment of purulent necrotic foot ulcers in patients with diabetes mellitus].
    Podpriatov SIe; Lisovets' VV; Huch AO; Tovkun VK; Slobodeniuk IM; Hupalo IuM
    Klin Khir; 2001 Feb; (2):27-9. PubMed ID: 11482020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regional anesthesia and timely treatment for neuropathy in patients with pyonecrotic forms of the diabetic foot].
    Orudzheva SA; Zviagin AA; Simonenkov AP; Tsvetkov VO; Kurochkina AI; Klenskiĭ SK; Braverman IB
    Anesteziol Reanimatol; 2005; (2):35-7. PubMed ID: 15938094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NO-therapy in the treatment of purulent and necrotic lesions of lower extremities in diabetic patients].
    Shulutko AM; Antropova NV; Kriuger IuA
    Khirurgiia (Mosk); 2004; (12):43-6. PubMed ID: 15699957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Algorhythm of diagnostic and treatment measures in the diabetic foot syndrome].
    Narchaev ZhA
    Klin Khir; 2009 Oct; (10):33-5. PubMed ID: 20458948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
    Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
    J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of classification and organization of medical care for diabetic patients with different forms of ulcerative-necrotic lesions of lower extremities].
    Udovichenko OV
    Klin Med (Mosk); 2016; 94(8):623-7. PubMed ID: 30290103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds.
    Beckert S; Pietsch AM; Küper M; Wicke C; Witte M; Königsrainer A; Coerper S
    Ann Surg; 2009 Apr; 249(4):677-81. PubMed ID: 19300218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Syndrome of diabetic foot and atherosclerosis of the lower extremity arteries].
    Kokobelian AR; Zigmantovich IuM
    Vestn Khir Im I I Grek; 2006; 165(3):74-8. PubMed ID: 16881182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The total contact cast: a method for treating neuropathic diabetic ulcers.
    Caputo GM; Ulbrecht JS; Cavanagh PR
    Am Fam Physician; 1997 Feb; 55(2):605-11, 615-6. PubMed ID: 9054227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ways of improvement in surgical treatment of purulent-necrotic complications in the diabetic foot syndrome].
    Antoniuk SM; Sviridov NV; Golovnia PF; Andrienko IB; Akhrameev VB; Lomako AI
    Klin Khir; 2002; (11-12):91-3. PubMed ID: 12549315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic foot: from diagnosis to therapy].
    Zucchi P; Ferrari P; Spina ML
    G Ital Nefrol; 2005; 22 Suppl 31():S20-2. PubMed ID: 15786395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human acellular dermal wound matrix for complex diabetic wounds.
    Rupert P
    J Wound Care; 2016 Apr; 25(4):S17-8, S20-1. PubMed ID: 27068343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compartment syndrome in patients with diabetic foot syndrome complicated by purulent necrotic lesions].
    Mikhnevych OE; Horielov SV; Bezliuda NP; Sapa SA
    Klin Khir; 2001 Aug; (8):33-5. PubMed ID: 11794107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC; Odenigbo CU; Oguejiofor CB
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of efficacy of second application of Urokinase Medac in a diabetic foot syndrome].
    Horobeĭko MB
    Klin Khir; 2014 Mar; (3):28-30. PubMed ID: 25097995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.